@Jil,
Understand why I am cautious with MRNA? Is in Primary degree wave 4, a multi-month corrective wave.
1 Like
Always better to buy stocks in wave three (REGN is in wave 3) than in wave four (MRNA is in wave 4).
1 Like
What can I say? You are happy with one day growth! You say MRNA still on corrective wave, Paul says it is in bullish wave. I can confidently tell you this. Your EW on MRNA is 100% wrong and Paul EW is right. You would not agree now. We agree to disagree here.
Let us sync after 30 days how do you feel?
Good news for MRNA. If conventional vaccines can match the efficacy of mRNA it will be a huge win.
2 Likes
has any vaccine globally went from SF bayarea?
whole SF Bayarea is standing on one dimensional economy of Software development which is fast replaceable.
Total BS. Tourism is the number one industry in San Francisco. Tourists in Austin… zero
1 Like
SF is very small part of SF Bayarea. and most people who work in resturants have shifts at multiple places. small business contribute to SF economic activity but is entirely depended on tech worker spending along with any conventions that were related to Tech firms.
Tourism is by product of Tech. as so many international flights to SFO and hence tourism depend on tech using those flights.
1 Like
1 Like
Further more 100 M each US order to BNTX and MRNA…non-stop orders…
1 Like
This news has already forced MRNA to over $150s.
1 Like
The reason is not financial performance related nor an acceptance of its future prospect. Surprisingly, it is one of the heavily shorted stocks in terms of dollars. Because of the GME fiasco, many short-selling hedge funds rush to cover their shorts, causing a huge jump in shorted names.
Calming down…
1 Like
So confident 
=> Why? I do not need someone else, like JC or Cathie, to tell what is best for me. I did my own research and convinced these two are better for me!
Yes and Yes, MRNA & BNTX is way better than TSLA and TQQQ, no doubt, but I can not guarantee future.
How? Will TSLA (752B) exceed or equal AAPL (2200B) market cap in one year? If answer is yes, then TSLA wins over MRNA. But MRNA & BNTX can double in a year.
I would have mentioned this many times. I missed the boat of TSLA, but do not want to miss this time with MRNA & BNTX.
Even now, you have a chance to get in MRNA and BNTX ! Monday, very likely they dip, and I also waiting for such chances to get some more addition !
Daily my trading partner asks the same question and I reply the same => I heard China has 130+ EV cars startup, still TSLA is leading and the same in USA. If you know your company is like “Usain Bolt”, you will still win, and others will be behind the first.
However, I closed some of the MRNA calls yesterday (113% jump) when it peaked to $193 and will be buying back tomorrow or sometime later when it dips.
Second, any company can go down any time, during this kind of dip time, I need lot of cash to bottom fishing when we see deep discount value, be it MRNA or TSLA or TQQQ.
The market wild run is not yet over, still to come (IMO).
BTW: There is no guarantee that my guesses will be correct, and I may be biased too about my holdings. Do not take any action based on these comments.
ok so my understanding is NVAX is also inferior to MRNA by your research?
Not really ! I can not say NVAX is inferior or superior than MRNA.
NVAX (The 89.3% efficacy rate in the U.K. is a blended result of efficacy against the original and the U.K. strain (B.1.1.7). The vaccine was 96% efficacious against the Wuhan strain and 86% efficacious against the U.K. strain, Erck told Yahoo Finance in an interview Friday.)
I did not do any research on NVAX except long time before choosing MRNA and BNTX.
Almost all world orders are out to MRNA and BNTX, they are 95% success. They are winner and runner.
NVAX has to get UK and USA approval and then prepare for orders. It will take 6 months to roll out from now. By that time 25%-40% of Covid will be vanished with MRNA and BNTX.
Third, NVAX jumped 3056% in a year. If they did not secure orders or if they secure poor orders (say 20 or 40 Millions…like that), chances are there it can go to $40 level.
Whereas BNTX and MRNA secured 18 months orders and assurances presently and already applied millions of doses to people.
In short, NVAX is lame duck Fundamentally !
1 Like
Only thing keeping Tesla on top is China. When they come up with a dozen knock offs Tesla is doomed.
2 Likes
““This is greedy, and the taxpayers who have funded all of this should have expected better negotiation on the part of the U.S. government,” said Margaret Liu, a globally respected vaccine scientist who once worked for Merck and is now chairperson of the International Society for Vaccines.”
Ok c’mon. Did anyone seriously expect the US government to negotiate a deal??? Pharmaceutical companies are probably the #1 lobbyist in DC. Reps are there to do their bidding, not the public’s.
Selling is totally on your comfort and profit level.
See hanera already sold all his stocks!
As I said I am holding my stocks, but selling my calls as time decay is associated with calls.
First, this is a startup company, us based. It has long potential to grow, major change in medical technology!
I saw TDOC from $50 onwards, it growing rapidly.
Similar to it, MRNA has brighter prospects to grow in future.
This will not be driven by Reddit team ( Reddit is speculative and will come to end soon - wait and watch the fun ), but driven by fundamentals.
IMO, This is not a big wave, but a small pull back, I started accumulating with 25 shares or 50 shares and then DCA until 140 (if it comes that lowest).
Since I sold calls when MRNA hit $193, I have good cash position to buy shares now. Already started buying back shares at $164 (limit $165), 159 (Limit 160) , 156 (limit 157.50)…and BNTX at $113.
I just placed limit (GTC) order 50 shares for $155, $150 and 100 shares $145 and $140. I never know whether it will reach or not. It is like fish hook, if it reaches, I will get it.
Until both MRNA and BNTX reaches results day, both will not fall heavily.
This is my take, but anything can go wrong and any time.
1 Like
1 Like